Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2026-04-09 @ 12:33 PM
Study NCT ID:
NCT00516295
Status:
COMPLETED
Last Update Posted:
2014-09-02
First Post:
2007-08-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2009-00369
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None